Table 2 Treatment ranking measures in the example of all-grade treatment-related adverse events
From: Predictive P-score for treatment ranking in Bayesian network meta-analysis
Treatment | Mean (P-score) | Median | 95% credible interval |
|---|---|---|---|
Frequentist P-score: | |||
 1 | 0.365 | NA | NA |
 2 | 0.821 | NA | NA |
 3 | 0.677 | NA | NA |
 4 | 0.174 | NA | NA |
 5 | 0.096 | NA | NA |
 6 | 0.944 | NA | NA |
 7 | 0.432 | NA | NA |
Scaled rank in the NMA: | |||
 1 | 0.362 | 0.333 | (0.167, 0.500) |
 2 | 0.764 | 0.667 | (0.667, 1.000) |
 3 | 0.780 | 0.833 | (0.500, 1.000) |
 4 | 0.164 | 0.167 | (0.000, 0.500) |
 5 | 0.092 | 0.000 | (0.000, 0.333) |
 6 | 0.924 | 1.000 | (0.667, 1.000) |
 7 | 0.415 | 0.500 | (0.000, 0.833) |
Expected scaled rank in a new study: | |||
 1 | 0.360 | 0.365 | (0.190, 0.509) |
 2 | 0.748 | 0.749 | (0.588, 0.897) |
 3 | 0.757 | 0.771 | (0.488, 0.943) |
 4 | 0.202 | 0.174 | (0.008, 0.573) |
 5 | 0.141 | 0.124 | (0.009, 0.369) |
 6 | 0.873 | 0.897 | (0.613, 0.993) |
 7 | 0.418 | 0.413 | (0.155, 0.729) |